
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1168 | 1041 | 1168 | 1117 | 1243 | - |
Fund Return | 16.76% | 4.07% | 16.76% | 3.76% | 4.45% | - |
Place in category | 258 | 367 | 258 | 358 | 612 | - |
% in Category | 9 | 12 | 9 | 14 | 30 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B EUR | 1.36B | -1.00 | 2.00 | 8.81 | ||
Adamant Medtech I EUR | 1.36B | -0.83 | 2.71 | 9.59 | ||
Adamant Medtech T EUR | 1.36B | -0.90 | 2.40 | 9.25 | ||
Bellevues Lux BB Adamant Medtech HB | 1.36B | 2.19 | -1.22 | 6.95 | ||
LU1477743386 | 314.74M | -3.21 | -3.38 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch S Multiple Opf | 23.34B | 1.26 | 3.54 | 5.47 | ||
Flossbach von Storch S Multiple Opi | 23.34B | 1.20 | 3.42 | 5.11 | ||
Flossbach von Storch S Multiple Ope | 23.34B | 1.03 | 2.72 | 4.45 | ||
LU1663838545 | 13.99B | 0.30 | 2.86 | - | ||
Flossbach von Storch Multiple Oppot | 10.39B | 0.99 | 2.80 | 4.83 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SPDR S&P 500 UCITS | IE00B6YX5C33 | 15.02 | 409.23 | -0.30% | |
Xtrackers MSCI USA UCITS ETF 1C | IE00BJ0KDR00 | 7.91 | 140.00 | +0.85% | |
Xtrackers MSCI Emerging Markets UCITS | IE00BTJRMP35 | 5.47 | 50.298 | +0.89% | |
Btp Tf 1,50% Gn25 Eur | IT0005090318 | 3.37 | 99.90 | 0.00% | |
Xtrackers MSCI Japan UCITS 1C | LU0274209740 | 3.30 | 6,073.5 | +0.84% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review